Personnel Information

写真a

SAITOU Eiko


Job title

Junior Associate Professor
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2015.04
    -
    2019.10
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Systemic Organ Regulation， Gastroenterology and Hepatology， Visiting Lecturer
  • 2016.05
    -
    2017.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Systemic Organ Regulation， Gastroenterology and Hepatology， Visiting Lecturer
  • 2017.04
    -
    2019.10
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Hospital Departments， Department of Internal Medicine， Gastroenterology and Hepatology， Assistant Professor
  • 2019.11
    -
    2021.09
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Hospital Departments， Department of Internal Medicine， Gastroenterology and Hepatology， Assistant Professor
  • 2021.10
    -
    2023.03
    Tokyo Medical and Dental University， Tokyo Medical and Dental University， Division of Clinical Medicine， Department of Internal Medicine， Gastroenterology and Hepatology， Assistant Professor
  • 2023.04
    -
    Now
    Tokyo Medical and Dental University， Tokyo Medical and Dental University， Division of Integrated Facilities， Center for Personalized Medicine for Healthy Aging， Junior Associate Professor

▼display all

To the head of this page.▲

Qualification Acquired 【 display / non-display 】

  • Doctor

To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Ami Kawamoto, Kento Takenaka, Shuji Hibiya, Yoshio Kitazume, Hiromichi Shimizu, Toshimitsu Fujii, Eiko Saito, Kazuo Ohtsuka, Ryuichi Okamoto. Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopy. Intest Res. 2023.11; Online ahead of print ( PubMed, DOI )

  2. Fujiwara S, Kawamoto A, Motobayashi M, Hibiya S, Takenaka K, Shimizu H, Saito E, Fujii T, Nagahori M, Kawata D, Umezawa N, Hosoya T, Yasuda S, Ohtsuka K, Okamoto R. Hemorrhagic gastric ulcer in a patient with Behcet's disease successfully treated with infliximab. DEN open. 2023.04; 3 (1): e196. ( PubMed, DOI )

  3. Eiko Saito, Kazuo Ohtsuka, Ami Kawamoto, Toshimitsu Fujii, Kento Takenaka, Shuji Hibiya, Hiromichi Shimizu, Masakazu Nagahori, Shohei Tomii, Ryuichi Okamoto. A case of venous stasis colitis possibly caused by eplerenone. Clin J Gastroenterol. 2023.02; 16 (1): 69-72. ( PubMed, DOI )

  4. Shuji Hibiya, Kazuo Ohtsuka, Kento Takenaka, Ami Kawamoto, Yusuke Matsuyama, Yumi Udagawa, Maiko Motobayashi, Hiromichi Shimizu, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Ryuichi Okamoto, Mamoru Watanabe. Mucosal healing of small intestinal stricture is associated with improved prognosis post-dilation in Crohn's disease. BMC Gastroenterol. 2022.05; 22 (1): 218. ( PubMed, DOI )

  5. Hiromichi Shimizu, Toshimitsu Fujii, Kenji Kinoshita, Ami Kawamoto, Shuji Hibiya, Kento Takenaka, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe, Ryuichi Okamoto. Intravenous tacrolimus is a superior induction therapy for acute severe ulcerative colitis compared to oral tacrolimus. BMC Gastroenterol. 2021.12; 21 (1): 494. ( PubMed, DOI )

  6. Takenaka Kento, Kawamoto Ami, Hibiya Shuji, Suzuki Kohei, Fujii Toshimitsu, Motobayashi Maiko, Shimizu Hiromichi, Nagahori Masakazu, Saito Eiko, Okamoto Ryuichi, Watanabe Mamoru, Ohtsuka Kazuo. Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021.07; ( DOI )

  7. Kaneshiro Miyuki, Takenaka Kento, Suzuki Kohei, Fujii Toshimitsu, Hibiya Shuji, Kawamoto Ami, Motobayashi Maiko, Shimizu Hiromichi, Nagahori Masakazu, Saito Eiko, Okamoto Ryuichi, Ohtsuka Kazuo, Watanabe Mamoru. Pancolonic endoscopic and histologic evaluation for relapse prediction in patients with ulcerative colitis in clinical remission ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021.04; 53 (8): 900-907. ( DOI )

  8. Hibiya Shuji, Matsuyama Yusuke, Fujii Toshimitsu, Maeyashiki Chiaki, Saito Eiko, Ito Kimiko, Shimizu Hiromichi, Kawamoto Ami, Motobayashi Maiko, Takenaka Kento, Nagahori Masakazu, Kurosaki Masayuki, Yauchi Tsunehito, Ohtsuka Kazuo, Fujiwara Takeo, Okamoto Ryuichi, Watanabe Mamoru. 5-aminosalicylate-intolerant patients are at increased risk of colectomy for ulcerative colitis ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2021.01; 53 (1): 103-113. ( DOI )

  9. Hiromichi Shimizu, Toshimitsu Fujii, Shuji Hibiya, Maiko Motobayashi, Kohei Suzuki, Kento Takenaka, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis. Intest Res. 2020.06; Online ahead of print.. ( PubMed, DOI )

  10. Takenaka Kento, Ohtsuka Kazuo, Fujii Toshimitsu, Negi Mariko, Suzuki Kohei, Shimizu Hiromichi, Oshima Shiori, Akiyama Shintaro, Motobayashi Maiko, Nagahori Masakazu, Saito Eiko, Matsuoka Katsuyoshi, Watanabe Mamoru. Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients With Ulcerative Colitis GASTROENTEROLOGY. 2020.06; 158 (8): 2150-2157. ( DOI )

  11. Fujii T., Hibiya S., Maeyashiki C., Saito E., Takenaka K., Motobayashi M., Shimizu H., Nagahori M., Ohtsuka K., Kurosaki M., Yauchi T., Watanabe M.. Intolerance to 5-aminosalicylate is a risk of poor prognosis in ulcerative colitis patients JOURNAL OF CROHNS & COLITIS. 2020.01; 14 S409-S410.

  12. Kento Takenaka, Toshimitsu Fujii, Kohei Suzuki, Hiromichi Shimizu, Maiko Motobayashi, Shuji Hibiya, Eiko Saito, Masakazu Nagahori, Mamoru Watanabe, Kazuo Ohtsuka. Small Bowel Healing Detected by Endoscopy in Patients With Crohn's Disease After Treatment With Antibodies Against Tumor Necrosis Factor. Clin. Gastroenterol. Hepatol.. 2019.08; ( PubMed, DOI )

  13. Shintaro Akiyama, Katsuyoshi Matsuoka, Kyoko Fukuda, Shunsuke Hamada, Mikiko Shimizu, Kosaku Nanki, Shinta Mizuno, Hiroki Kiyohara, Mari Arai, Shinya Sugimoto, Yasushi Iwao, Haruhiko Ogata, Tadakazu Hisamatsu, Makoto Naganuma, Maiko Motobayashi, Kohei Suzuki, Kento Takenaka, Toshimitsu Fujii, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mayumi Mochizuki, Mamoru Watanabe, Masayuki Hashiguchi, Takanori Kanai. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine. J. Gastroenterol. Hepatol.. 2019.05; ( PubMed, DOI )

  14. Ozaki R, Kobayashi T, Okabayashi S, Nakano M, Morinaga S, Hara A, Ohbu M, Matsuoka K, Toyonaga T, Saito E, Hisamatsu T, Hibi T. Histological Risk Factors to Predict Clinical Relapse in Ulcerative Colitis With Endoscopically Normal Mucosa. Journal of Crohn's & colitis. 2018.11; 12 (11): 1288-1294. ( PubMed, DOI )

  15. Fumihiko Iwamoto, Katsuyoshi Matsuoka, Maiko Motobayashi, Kento Takenaka, Toru Kuno, Keisuke Tanaka, Yuya Tsukui, Shoji Kobayashi, Takashi Yoshida, Toshimitsu Fujii, Eiko Saito, Tatsuya Yamaguchi, Masakazu Nagahori, Tadashi Sato, Kazuo Ohtsuka, Nobuyuki Enomoto, Mamoru Watanabe. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy. J. Gastroenterol. Hepatol.. 2018.06; ( PubMed, DOI )

  16. Kento Takenaka, Kazuo Ohtsuka, Yoshio Kitazume, Katsuyoshi Matsuoka, Masakazu Nagahori, Toshimitsu Fujii, Eiko Saito, Maiko Kimura, Tomoyuki Fujioka, Mamoru Watanabe. Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.[Epub ahead of print] Am. J. Gastroenterol.. 2017.12; ( PubMed, DOI )

  17. Okabayashi S, Kobayashi T, Sujino T, Ozaki R, Umeda S, Toyonaga T, Saito E, Nakano M, Tablante MC, Morinaga S, Hibi T. Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab. Intestinal research. 2017.10; 15 (4): 535-539. ( PubMed, DOI )

  18. Ozaki R., Kobayashi T., Saito E., Toyonaga T., Okabayashi S., Umeda S., Nakano M., Matsuoka K., Morinaga S., Hisamatsu T., Hibi T.. Histological risk factors to predict clinical relapse in ulcerative colitis in mucosal healing JOURNAL OF CROHNS & COLITIS. 2017.02; 11 S226.

  19. Toyonaga T, Kobayashi T, Nakano M, Saito E, Umeda S, Okabayashi S, Ozaki R, Hibi T. Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome. PloS one. 2017; 12 (9): e0185131. ( PubMed, DOI )

  20. Toshimitsu Fujii, Makoto Naganuma, Yoshio Kitazume, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. Advancing magnetic resonance imaging in Crohn's disease. Digestion. 2014.01; 89 (1): 24-30. ( PubMed, DOI )

  21. Eiko Saito, Masakazu Nagahori, Toshimitsu Fujii, Kazuo Ohtsuka, Mamoru Watanabe. Efficacy of salvage therapy and its effect on operative outcomes in patients with ulcerative colitis. Digestion. 2014.01; 89 (1): 55-60. ( PubMed, DOI )

  22. Makoto Naganuma, Toshimitsu Fujii, Reiko Kunisaki, Naoki Yoshimura, Masakazu Takazoe, Yoshiaki Takeuchi, Eiko Saito, Masakazu Nagahori, Keiko Asakura, Toru Takebayashi, Mamoru Watanabe. Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients. J Crohns Colitis. 2013.05; 7 (4): 308-313. ( PubMed, DOI )

  23. Makoto Naganuma, Masakazu Nagahori, Toshimitsu Fujii, Junko Morio, Eiko Saito, Mamoru Watanabe. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD. Inflamm. Bowel Dis.. 2013.02; 19 (2): 418-422. ( PubMed, DOI )

  24. Kyohei Fujita, Makoto Naganuma, Eiko Saito, Shinji Suzuki, Akihiro Araki, Mariko Negi, Hiroshi Kawachi, Mamoru Watanabe. Histologically confirmed IgG4-related small intestinal lesions diagnosed via double balloon enteroscopy. Dig. Dis. Sci.. 2012.12; 57 (12): 3303-3306. ( PubMed, DOI )

  25. Hea Saeng Koh, Atsushi Matsui, Sumie Mimura, Mie Inao, Eiko Saitoh, Akihiko Ohno, Sumiko Nagoshi, Takayuki Yoshimoto, Satoshi Mochida, Kenji Fujiwara. Increased cytoprotective function in the liver of transgenic mice expressing osteopontin in hepatocytes. Hepatol Res. 2005.05; 32 (1): 46-51. ( PubMed, DOI )

  26. Eiko Saitoh, Atsushi Matsui, Mie Inao, Sumie Mimura, Heasaeng Koh, Akihiko Ohno, Sumiko Nagoshi, Hidekazu Kayano, Takayuki Yoshimoto, Satoshi Mochida, Kenji Fujiwara. Extrahepatic manifestations in transgenic mice of osteopontin in hepatocytes-A clue to advent of pathological state in various organs of chronic hepatitis C patients. Hepatol Res. 2005.04; 31 (4): 197-202. ( PubMed, DOI )

  27. Satoshi Mochida, Takayuki Yoshimoto, Sumie Mimura, Mie Inao, Atsushi Matsui, Akihiko Ohno, HeaSaeng Koh, Eiko Saitoh, Sumiko Nagoshi, Kenji Fujiwara. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis. Biochem Biophys Res Commun. 2004.04; 317 (1): 114-120. ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. T. Fujii , S. Hibiya , H. Shimizu , A. Kawamoto , K. Takenaka , E. Saito , M. Nagahori , K. Ohtsuka , R. Okamoto. DUAL THERAPY WITH CAROTEGRAST (AJM300: ORAL α4 INTEGRIN ANTAGONIST) AND BIOLOGICS FOR REFRACTORY ULCERATIVE COLITIS. UEGW2023 2023.10.15

  2. A. Kawamoto, K. Takenaka, S. Hibiya, Y. Kitazume, K. Ito, H. Shimizu, T. Fujii, E. Saito, K. Ohtsuka, R. Okamoto. COMBINING LEUCINE-RICH ALPHA-2 GLYCOPROTEIN AND FAECAL BIOMARKERS FOR ACCURATE MONITORING OF SMALL BOWEL ACTIVITY IN CROHN’S DISEASE. UEG Week 2023.10.14

  3. 土屋輝一郎、長堀正和、日比谷秀爾、竹中健人、河本亜美、清水寛路、藤井俊光、齊藤詠子、大塚和朗、渡辺　守、岡本隆一 . 【誌面発表】COVID-19蔓延下におけるスマートデバイスを用いたIBD病診連携に関する研究. 厚生労働科学研究費 難治性疾患政策研究事業 「難治性炎症性腸管障害に関する調査研究」令和3年度 第1回総会 2021.07.15 Web開催

  4. Takashi Nagaishi, Daiki Yamada, Naoya Tsugawa, Taro Watabe, Eiko Saito, Masayoshi Fukuda, Ayako Arai, Kazuo Ohtsuka, Mamoru Watanabe. A case of villous atrophy with CCR4+ T cell infiltration in the small intestine.. UEGW2020 2020.10.10 Web開催

  5. Toshimitsu Fujii, Shuji Hibiya, Chiaki Maeyashiki, Eiko Saito, Kento Takenaka, Maiko Motobayashi, Hiromichi Shimizu, Masakazu Nagahori, Kazuo Ohtsuka, Masayuki Kurosaki, Tsunehito Yauchi, Mamoru Watanabe. Intolerance to 5-aminosalicylate is a risk of poor prognosis in Ulcerative colitis patients.. ECCO2020 2020.02.14 Vienna（Austria）

  6. Eiko Saito, Kohei Suzuki, Shuuji Hibiya, Maiko Motobayashi, Kento Takenaka, Nobukatsu Horita, Hiromichi Shimizu, Michio Onizawa, Toshimitsu Fujii, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. The clinical efficacy of ustekinumab (UST) in patients with Crohn’s disease (CD). AOCC2019 2019.06.15 Taipei（Taiwan）

  7. Kento Takenaka, Kazuo Ohtsuka, Toshimitsu Fujii, Kohei Suzuki, Hiromichi Shimizu, Maiko Motobayashi, Shuji Hibiya, Eiko Saito, Masakazu Nagahori, Mamoru Watanabe. Small bowel endoscopic healing of Crohn’s disease treated with anti-TNF antibodies. The 7th Annual Meeting of Asian Organization for Crohn's and Colitis (AOCC 2019) 2019.06.15 台北

  8. Takenaka K, Ohtsuka K, Fujii T, Nagahori M, Saito E, Motobayashi M, Suzuki K, Watanabe M. Small bowel mucosal healing of Crohn’s disease treated with anti-TNF antibodies. FALKシンポジウム 2018.09.07 京都ホテルオークラ（京都府京都市）

  9. Saito E, Suzuki K, Shimizu H, Motobayashi M, Takenaka K, Onizawa M, Fujii T, Nagahori M, Ohtsuka K, Watanabe M. The clinical efficacy of switching cases between Infliximab(IFX) andAdalimumab(ADA) in patients with ulcerative colitis. AOCC2018 2018.06.22 Shanghai （China）

  10. Ohtsuka K, Takenaka K, Suzuki K, Fujii T, Nagahori M, Matsuoka K, Saito E, Katsukura N, Fukuda M, Araki A, Watanabe M. Usefulness of single-balloon enteroscopy: from a single center 990 experiences. DDW2018 2018.06.03 Washington D.C (USA）

  11. T. Fujii Y. Kitazume K. Takenaka M. Kimura E. Saito K. Matsuoka M. Nagahori K. Ohtsuka M. Watanabe. Simplified MR enterocolonography Classification Based on Endoscopic Findings for Activity Assessment of Crohn’s Disease. UEGW2017 (欧州消化器病学会週間2017） 2017.11.01 Barcelona(Spain)

  12. Toyonaga T, Kobayashi T, Kuronuma S, Takeuchi O, Nakano M, Saito E, Umeda S, Okabayashi S, Ozaki R, Hibi T . Patient-Reported outcome is more reliable than fecal calprotectin in detecting early response to remission induction treatment in ulcerative colities. AOCC2017 2017.06.17 Seoul (Korea)

  13. Saito E, Kobayashi T, Ozaki R, Okabayashi S, Umeda S, Nakano M, Toyonaga T, Kuronuma S, Takeuchi O, Hibi T. Is inflliximab blood concentration measurement of patients with IBD useful for optimization?. AOCC2017 2017.06.16 Seoul (Korea)

  14. Maiko Kimura, Katsuyoshi Matsuoka, Eiko Saito, Toshimitsu Fujii, Kento Takenaka, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe. Salvage therapy for corticosteroid-refractory ulcerative colitis patients. AOCC2016 2016.07.07 Kyoto International Conference Center, Kyoto（JAPAN）

  15. Fujii T, Naganuma M, Saito E, Nagahori M, Watanabe M. Intravenous tacrolimus therapy can rapidly induce remission in refractory ulcerative colitis. DDW2012 2012.05.19 San Diego

▼display all

To the head of this page.▲